8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jul 29, 2024 · 1y ago · Accession 0001193125-24-186747
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NewAmsterdam Pharma Co N.V.
- Ticker
- NAMS
- CIK
- 1936258
- Form type
- 8-K
- Filing date
- Jul 29, 2024
- Report date
- Jul 29, 2024
- Document
- d660026d8k.htm
- Size
- 2.4 MB